These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 22622628)

  • 1. Anxiety and methylphenidate in attention deficit hyperactivity disorder: a double-blind placebo-drug trial.
    Moshe K; Karni A; Tirosh E
    Atten Defic Hyperact Disord; 2012 Sep; 4(3):153-8. PubMed ID: 22622628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder.
    Gorman EB; Klorman R; Thatcher JE; Borgstedt AD
    J Am Acad Child Adolesc Psychiatry; 2006 Jul; 45(7):808-16. PubMed ID: 16832317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of methylphenidate on prepulse inhibition during attended and ignored prestimuli among boys with attention-deficit hyperactivity disorder.
    Hawk LW; Yartz AR; Pelham WE; Lock TM
    Psychopharmacology (Berl); 2003 Jan; 165(2):118-27. PubMed ID: 12417963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of subjective and objective changes in motor activity and attention in children with attention-deficit/hyperactivity disorder in a double-blind methylphenidate trial.
    Konrad K; Günther T; Heinzel-Gutenbrunner M; Herpertz-Dahlmann B
    J Child Adolesc Psychopharmacol; 2005 Apr; 15(2):180-90. PubMed ID: 15910203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in attentional performance and their modulation by methylphenidate in children with attention-deficit/hyperactivity disorder.
    Günther T; Herpertz-Dahlmann B; Konrad K
    J Child Adolesc Psychopharmacol; 2010 Jun; 20(3):179-86. PubMed ID: 20578930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
    Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
    J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modafinil as a treatment for Attention-Deficit/Hyperactivity Disorder in children and adolescents: a double blind, randomized clinical trial.
    Amiri S; Mohammadi MR; Mohammadi M; Nouroozinejad GH; Kahbazi M; Akhondzadeh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):145-9. PubMed ID: 17765380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attention deficit disorder and the effect of methylphenidate on attention, behavioral, and cardiovascular functioning.
    Brown RT; Wynne ME; Slimmer LW
    J Clin Psychiatry; 1984 Nov; 45(11):473-6. PubMed ID: 6386794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylphenidate and comorbid anxiety disorder in children with both chronic multiple tic disorder and ADHD.
    Gadow KD; Nolan EE
    J Atten Disord; 2011 Apr; 15(3):246-56. PubMed ID: 20378921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of methylphenidate on word decoding accuracy in boys with attention-deficit/hyperactivity disorder.
    Bental B; Tirosh E
    J Clin Psychopharmacol; 2008 Feb; 28(1):89-92. PubMed ID: 18204348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.
    Biederman J; Pliszka SR
    J Pediatr; 2008 Mar; 152(3):394-9. PubMed ID: 18280848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial.
    Salehi B; Imani R; Mohammadi MR; Fallah J; Mohammadi M; Ghanizadeh A; Tasviechi AA; Vossoughi A; Rezazadeh SA; Akhondzadeh S
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):76-80. PubMed ID: 19815048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selegiline in the treatment of attention deficit hyperactivity disorder in children: a double blind and randomized trial.
    Akhondzadeh S; Tavakolian R; Davari-Ashtiani R; Arabgol F; Amini H
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):841-5. PubMed ID: 12921918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, placebo-controlled trial of dexmethylphenidate hydrochloride and d,l-threo-methylphenidate hydrochloride in children with attention-deficit/hyperactivity disorder.
    Wigal S; Swanson JM; Feifel D; Sangal RB; Elia J; Casat CD; Zeldis JB; Conners CK
    J Am Acad Child Adolesc Psychiatry; 2004 Nov; 43(11):1406-14. PubMed ID: 15502600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bupropion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder.
    Barrickman LL; Perry PJ; Allen AJ; Kuperman S; Arndt SV; Herrmann KJ; Schumacher E
    J Am Acad Child Adolesc Psychiatry; 1995 May; 34(5):649-57. PubMed ID: 7775360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of methylphenidate on motor performance and attention in children with developmental coordination disorder and attention deficit hyperactive disorder.
    Bart O; Daniel L; Dan O; Bar-Haim Y
    Res Dev Disabil; 2013 Jun; 34(6):1922-7. PubMed ID: 23584172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of methylphenidate on aggressive urban children with attention deficit hyperactivity disorder.
    Bukstein OG; Kolko DJ
    J Clin Child Psychol; 1998 Oct; 27(3):340-51. PubMed ID: 9789193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bupropion versus methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder: randomized double-blind study.
    Jafarinia M; Mohammadi MR; Modabbernia A; Ashrafi M; Khajavi D; Tabrizi M; Yadegari N; Akhondzadeh S
    Hum Psychopharmacol; 2012 Jul; 27(4):411-8. PubMed ID: 22806822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
    Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
    Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.